Protocol Ledger

NCT06184009 · Phase II · RECRUITING

Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia

Interventional Phase II clinical trial protocol NCT06184009 sponsored by Jae Wook Lee in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-08-10 Enrollment: 370 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06184009
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)370 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06184009
Protocol FieldVerified Registry Value
NCT IdentifierNCT06184009
Consolidated Lead SponsorJae Wook Lee
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment370 participants (ESTIMATED)
Registered Start Date2024-08-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06184009
Hospital Research SiteLocationSite Profile
Seoul National University HospitalSeoul, South KoreaOpen Hospital Dossier ->
Samsung Medical CenterSeoul, South KoreaOpen Hospital Dossier ->
Inha University HospitalIncheon, South KoreaOpen Hospital Dossier ->
Korea University Anam HospitalSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI